The dopastatin BIM-23A760 distinctly influences key functional endpoints in different types of pituitary adenomas and normal pituitaries: role of somatostatin and dopamine receptor profile
Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Raúl M. Luque(Instituto de Salud Carlos III), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Alberto Moreno-Carazo(Complejo Hospitalario de Jaén), Miguel Á. Japón(Instituto de Biomedicina de Sevilla), Eva Venegas‐Moreno(Hospital Universitario Virgen del Rocío), Michael D. Culler(Ipsen (United States)), la Riva Andres de, Esther Rivero‐Cortés(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Susan M. Webb(Universitat Autònoma de Barcelona), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Laura M. López‐Sánchez(Instituto Maimónides de Investigación Biomédica de Córdoba), Francisco J. Tinahones(Instituto de Salud Carlos III), Rhonda D. Kineman(University of Illinois Chicago), Alfonso Soto‐Moreno(Instituto de Biomedicina de Sevilla), Luis Jiménez‐Reina(University of Córdoba), Silvia Maraver-Selfa(Hospital Clínico Universitario Virgen de la Victoria), Mari C. Vázquez‐Borrego(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), María A. Gálvez(Hospital Universitario Reina Sofía), Juan Antonio García-Arnés
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
|Nutrition Reviews|2017|414
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325
Does gut hormone PYY3–36 decrease food intake in rodents?
|Nature|2004|295